A study on RFA combined with surgical resection for non-small cell lung cancer showed intense infiltrations of CD4+ and CD8+ lymphocytes at the perimeter of the RFA-treated tumor tissue. The gene discussed is CD4; the disease is non-small cell lung carcinoma.